This article was originally published in The Tan Sheet
Executive SummaryMulti-center trial to evaluate effects of folate supplementation on occurrence of Down's syndrome underway following research finding link between disorder and neural tube defects. Gad Barkai, Tel Aviv University, et al., studied women in Israel and the Ukraine, finding "periconceptional folic acid supplementation should be recommended" for mothers who have already had a child with Down's syndrome, since they are likely at an increased risk for having another child with neural tube defects. Study in April 19 The Lancet followed 493 families in Israel with high NTD risk, 516 families in the Ukraine with high risk for Down's syndrome. Barkai et al. examined medical records with information on maternal age, pregnancy outcome and congenital malformations...
You may also be interested in...
After two Indian vaccine makers, Serum Institute of India and Cadila Healthcare joined the fight against COVID-19, Bharat Biotech may follow suit. Others like Hilleman have decided against it for the moment while Panacea Biotech is weighing the pros and cons of developing a SARS-CoV-2 vaccine after a sour experience with H1N1.
South Korea’s HLB has begun a new growth phase by taking over US-based clinical stage biotech firm Immunomic Therapeutics. Through the acquisition, it is poised to add new pipeline assets including a Phase II vaccine therapy for glioblastoma and proprietary lysosomal targeting technology.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.